2013 Cell Biology of Megakaryocytes and Platelets GRC & GRS
2013 Cell Biology of Megakaryocytes and Platelets GRC & GRS
批准号:
8450490
负责人:
KATYA RAVID
金额:
$0.5万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-03-01 至 2014-02-28
关键词:
AcademiaAttentionBasic ScienceBiologyBlood PlateletsCardiovascular DiseasesCardiovascular PathologyCaringCellsCellular biologyCoagulation ProcessCollaborationsCommunitiesCoupledCytoskeletonDevelopmentDisciplineDiseaseFacultyFutureGoalsHealthHematological DiseaseInflammatoryInstitutesIslandKnowledgeLearningMedicalMegakaryocytesMegakaryocytopoiesesMentorsMethodsMexicoMicroRNAsMissionMyeloproliferative diseaseMyocardial InfarctionNamesOralPathologicPathologyPharmacologic SubstancePreventionProcessRequest for ApplicationsResearchResearch PersonnelRunningScienceScientistSignal TransductionSolidStrokeTalentsTexasThrombopoiesisThrombosisThrombusTimeTrainingabstractingbench to bedsidecareercostembryonic stem cellexperiencefrontiergenome wide association studyimmune functionimprovedinnovationinsightinterdisciplinary approachinterestmeetingsmimeticsnovelnovel therapeuticsprogramspublic health relevancescreeningsoundsymposiumthrombocytosistool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Abnormal thrombopoiesis and thrombosis contribute to an array of hematological and cardiovascular pathologies, thus, requiring continued research and educational efforts. The Gordon Research Conference (GRC) on the Cell Biology of Megakaryocytes and Platelets is the premier scientific meeting focused on the biology of megakaryocytes (MKs) and the platelets that arise from them. This will be the 5th biennial meeting that brings together two groups of scientists with complimentary goals and interests. Our meeting will begin with processes governing megakaryopoiesis and thrombopoiesis, including from inducible pluripotent and embryonic stem cells, moving to novel computational and screening methods to study theses processes, transitioning to the cell biology of these cells in the context of the cytoskeleton, and then to newly identified signaling, inflammatory and immune functions in MKs and platelets. This plan then leads smoothly to a session centered on discoveries related to MK and platelet pathology. In addition, there is a whole session devoted to presentations of Hot Topics, selected from submitted abstracts. There are several innovative aspects to the planned meeting, including 1. The sessions cover within the same cluster processes that govern MK and platelet development and function, thus, allowing convergence of two audiences with overlapping interests, further increasing exchange of perspectives; 2. The translational potential is illustrated in a new session titled: From Bench to Bed Side, and talks, such as on novel therapeutic options for thrombocytosis associated with myeloproliferative neoplasm; 3. Emphasis on multidisciplinary approaches is exemplified in several sessions; and 4. Inclusion, for the first time, of a session titled: Breaking Paradigms in MK and Platelet Biolog provides opportunities to learn about, and discuss new paradigms that challenge older concepts in the field. The retention of the Gordon Research Seminar (GRS) for the 2013 meeting is important. This venue encourages promising trainees to participate more visibly in the program and possibly be encouraged to continue and develop a career in MK and platelet biology. A novel aspect in the GRS plan involves a talk on a historical overview of discovery in MK/platelet biology. Abstracts submitted by trainees will be scored by a panel, and selected for oral presentations, of which some will also present under Hot Topics in the GRC. Round table discussions with investigators will provide mentoring related to careers in academia and in pharmaceutical companies. Taken together, we believe that the planned GRC/GRS represent the Frontiers of Science for our discipline, with keen attention to mentoring. The GRS/GRC meetings take place from March 9-10th and 10-15th, 2013, respectively, at the historic Hotel Galvez, Galveston Island, Texas, located on the Gulf of Mexico. With the unique surroundings of wide beaches and numerous attractions on and near the island, this will be an exciting and memorable venue for all attendees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Megakaryocyte Mechanosensing Toward Platelet Biogenesis
-
批准号:10275022
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2021
-
负责人:KATYA RAVID
-
依托单位:
Megakaryocyte Mechanosensing Toward Platelet Biogenesis
-
批准号:10666544
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2021
-
负责人:KATYA RAVID
-
依托单位:
Megakaryocyte Mechanosensing Toward Platelet Biogenesis
-
批准号:10473789
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2021
-
负责人:KATYA RAVID
-
依托单位:
A path to thrombosis in primary myelofibrosis
-
批准号:10064585
-
项目类别:
-
资助金额:$47.67万
-
财政年份:2017
-
负责人:KATYA RAVID
-
依托单位:
Generation of IL-33 Deficient Mice
-
批准号:7963648
-
项目类别:
-
资助金额:$8.13万
-
财政年份:2010
-
负责人:KATYA RAVID
-
依托单位:
Generation of IL-33 Deficient Mice
-
批准号:8072091
-
项目类别:
-
资助金额:$8.04万
-
财政年份:2010
-
负责人:KATYA RAVID
-
依托单位:
Adenosine Receptors and Atherogenesis
-
批准号:8235840
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2009
-
负责人:KATYA RAVID
-
依托单位:
Adenosine Receptors and Atherogenesis
-
批准号:8035319
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2009
-
负责人:KATYA RAVID
-
依托单位:
Adenosine Receptors and Atherogenesis
-
批准号:7789620
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2009
-
负责人:KATYA RAVID
-
依托单位:
Adenosine Receptors and Atherogenesis
-
批准号:7645247
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2009
-
负责人:KATYA RAVID
-
依托单位:
Mechanisms Regulating Megakaryocyte Endomitosis
-
批准号:7393094
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2006
-
负责人:KATYA RAVID
-
依托单位:
Mechanisms Regulating Megakaryocyte Development
-
批准号:8291763
-
项目类别:
-
资助金额:$40.91万
-
财政年份:2006
-
负责人:KATYA RAVID
-
依托单位:
Mechanisms Regulating Megakaryocyte Development
-
批准号:8645684
-
项目类别:
-
资助金额:$40.11万
-
财政年份:2006
-
负责人:KATYA RAVID
-
依托单位:
Mechanisms Regulating Megakaryocyte Endomitosis
-
批准号:7591681
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2006
-
负责人:KATYA RAVID
-
依托单位:
Mechanisms Regulating Megakaryocyte Development
-
批准号:8435358
-
项目类别:
-
资助金额:$38.96万
-
财政年份:2006
-
负责人:KATYA RAVID
-
依托单位:
Mechanisms Regulating Megakaryocyte Endomitosis
-
批准号:7188613
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2006
-
负责人:KATYA RAVID
-
依托单位:
Mechanisms Regulating Megakaryocyte Endomitosis
-
批准号:7099910
-
项目类别:
-
资助金额:$40.56万
-
财政年份:2006
-
负责人:KATYA RAVID
-
依托单位:
ADENOSINE RECEPTORS IN VASCULAR FUNCTION
-
批准号:7413526
-
项目类别:
-
资助金额:$31.73万
-
财政年份:2006
-
负责人:KATYA RAVID
-
依托单位:
Mechanisms Regulating Megakaryocyte Endomitosis
-
批准号:7797598
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2006
-
负责人:KATYA RAVID
-
依托单位:
Adenosine receptors in vascular function
-
批准号:6998548
-
项目类别:
-
资助金额:$32.5万
-
财政年份:2004
-
负责人:KATYA RAVID
-
依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈立达
-
依托单位: